Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) As described below, the shareholders of AngioDynamics, Inc. ("AngioDynamics") voted on October 13, 2020 to approve the AngioDynamics, Inc. 2020 Equity Incentive Plan (the "2020 Plan"). The material terms of the 2020 Plan are described in Proposal 4 included in AngioDynamics' definitive proxy statement filed with the Securities and Exchange Commission on September 3, 2020 (the "Proxy Statement"), which description does not purport to be complete and is qualified in its entirety by reference to the full text of the 2020 Plan, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. In addition, the shareholders of AngioDynamics voted on October 13, 2020 to approve the amended AngioDynamics, Inc. Employee Stock Purchase Plan (the "ESPP"). The material terms of the ESPP are described in Proposal 5 included in the Proxy Statement, which description does not purport to be complete and is qualified in its entirety by reference to the full text of the ESPP, which is attached as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.07 - Submission of Matters to a Vote of Security Holders.

(a) The Annual Meeting of Shareholders of AngioDynamics was held on October 13, 2020.

(b) Shareholders of AngioDynamics voted on the matters set forth below.



    1. The nominees for election to the Board of Directors were elected, each as
       a Class II director to serve until the 2023 Annual Meeting of Shareholders
       of AngioDynamics and until their respective successors are duly elected
       and qualified, based upon the following votes:




  Nominee            Votes For  Withheld  Broker Non-Votes
  Eileen O. Auen     31,335,139  438,558     2,430,599
  James C. Clemmer   30,404,677 1,369,020    2,430,599
  Howard W. Donnelly 30,068,164 1,705,533    2,430,599
  Jan Stern Reed     31,106,052  667,645     2,430,599




    2. The proposal to ratify the appointment of Deloitte & Touche LLP as
       AngioDynamics' independent registered public accounting firm for the
       fiscal year ending May 31, 2021 was approved based upon the following
       votes:



  Votes for approval                 34,152,718
  Votes against                        40,792
  Abstention                           10,786
  There were no broker non-votes for this item.




    3. The proposal to approve, on an advisory basis, AngioDynamics' executive
       compensation of its named executive officers was approved based upon the
       following votes:



  Votes for approval   30,783,204
  Votes against         983,044
  Abstention             7,449
  Broker non-votes     2,430,599




    4. The proposal to approve the AngioDynamics, Inc. 2020 Equity Incentive Plan
       was approved based upon the following votes:



  Votes for approval   29,481,258
  Votes against        2,283,680
  Abstention             8,759
  Broker non-votes     2,430,599

--------------------------------------------------------------------------------




    5. The proposal to approve the amended AngioDynamics, Inc. Employee Stock
       Purchase Plan was approved based upon the following votes:



  Votes for approval   31,441,157
  Votes against         325,603
  Abstention             6,937
  Broker non-votes     2,430,599


Item 9.01 - Financial Statements and Exhibits.
(d)       Exhibits.

Exhibit No.     Description

  10.1          AngioDynamics, Inc. 2020 Equity Incentive Plan (Incorporated by
                reference to Appendix A of the Registrant's Definitive Proxy
                Statement filed on September 3, 2020 in connection with the
                Annual Meeting held on October 13, 2020 (File No. 000-50761)).

  10.2          AngioDynamics, Inc. Employee Stock Purchase Plan (Incorporated by
                reference to Appendix B of the Registrant's Definitive Proxy
                Statement filed on September 3, 2020 in connection with the
                Annual Meeting held on October 13, 2020 (File No. 000-50761)).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses